Author:
Rugo H. S.,Finn R. S.,Diéras V.,Ettl J.,Lipatov O.,Joy A. A.,Harbeck N.,Castrellon A.,Iyer S.,Lu D. R.,Mori A.,Gauthier E. R.,Bartlett C. Huang,Gelmon K. A.,Slamon D. J.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios CH, Bergh J, Bhattacharyya G, Biganzoli L, Cardoso MJ, Carey L, Corneliussen-James D, Curigliano G, Dieras V, El Saghir N, Eniu A, Fallowfield L, Fenech D, Francis P, Gelmon K, Gennari A, Harbeck N, Hudis C, Kaufman B, Krop I, Mayer M, Meijer H, Mertz S, Ohno S, Pagani O, Papadopoulos E, Peccatori F, Pernault-Llorca F, Piccart MJ, Pierga JY, Rugo H, Shockney L, Sledge G, Swain S, Thomssen C, Tutt A, Vorobiof D, Xu B, Norton L, Winer E (2017) 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). Breast 31:244–259.
https://doi.org/10.1016/j.breast.2016.10.00
2. Rugo H, Rumble B, Macrae E, Barton DL, Connolly HK, Dickler MN, Fallowfield LA, Fowble B, Ingle JN, Jahanzeb M, Johnston SR, Korde LA, Khatcheressian J, M RS, Muss HB, Burstein HJ (2016) Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology guideline. J Clin Oncol 34:3069–3103.
https://doi.org/10.1200/JCO.2016.67.1487
3. National Comprehensive Cancer Network (2017) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Breast cancer. Version 4.2017
https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
. Accessed Feb 12 2018
4. Finn RS, Martin M, Rugo HS, Jones S, Im SA, Gelmon K, Harbeck N, Lipatov ON, Walshe JM, Moulder S, Gauthier E, Lu DR, Randolph S, Dieras V, Slamon DJ (2016) Palbociclib and letrozole in advanced breast cancer. N Engl J Med 375:1925–1936.
https://doi.org/10.1056/NEJMoa1607303
5. IBRANCE® (palbociclib) (2018) Full prescribing information. Pfizer Inc, New York
Cited by
288 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献